scholarly journals Human antithrombin III heterogeneity

Blood ◽  
1981 ◽  
Vol 57 (2) ◽  
pp. 229-232
Author(s):  
L Williams ◽  
G Murano
Keyword(s):  
Human Plasma ◽  
Antithrombin Iii ◽  
Agarose Gel ◽  
Normal Human Plasma ◽  
Congenital Deficiency ◽  
Single Donor ◽  
At Iii ◽  
Normal Human

Crossed immunoelectrophoretic patterns were obtained on three patients with a congenital deficiency of anti-thrombin III (AT-III), and on normal single donor and “pooled” plasma controls. In the presence of heparin (incorporated into the agarose gel matrix), the AT-III of normal human plasma was separated into four components: two major, faster-moving components, and two minor, slower-moving components. The three patients with congenital deficiency of AT-III (levels approximately 50% of normal) appeared to possess only one of the faster- moving components, and one of the slower-moving components.

scholarly journals Human antithrombin III heterogeneity

Blood ◽  
1981 ◽  
Vol 57 (2) ◽  
pp. 229-232 ◽  
Author(s):  
L Williams ◽  
G Murano
Keyword(s):  
Human Plasma ◽  
Antithrombin Iii ◽  
Agarose Gel ◽  
Normal Human Plasma ◽  
Congenital Deficiency ◽  
Single Donor ◽  
At Iii ◽  
Normal Human

Abstract Crossed immunoelectrophoretic patterns were obtained on three patients with a congenital deficiency of anti-thrombin III (AT-III), and on normal single donor and “pooled” plasma controls. In the presence of heparin (incorporated into the agarose gel matrix), the AT-III of normal human plasma was separated into four components: two major, faster-moving components, and two minor, slower-moving components. The three patients with congenital deficiency of AT-III (levels approximately 50% of normal) appeared to possess only one of the faster- moving components, and one of the slower-moving components.

A Hitherto Undescribed Naturally Occurring Plasma Antagonist of Activated Factor X Inhibitor (Antithrombin III)

1979 ◽  
Author(s):  
E. T. Yin ◽  
W. J. Salsgiver ◽  
O. Tangen
Keyword(s):  
Equilibrium State ◽  
Human Plasma ◽  
Antithrombin Iii ◽  
Circumstantial Evidence ◽  
Incubation Mixture ◽  
Factor X ◽  
Normal Human Plasma ◽  
Plasma Component ◽  
Naturally Occurring ◽  
Normal Human

Circumstantial evidence suggested that normal human plasma contained a substance regulating the neutralization of F.Xa by F.Xa inhibitor(XaI), (Yin et.al.,Adv.Exper. Med. & Biol., 52 : 239, 1975, Plenum Press, N.Y.).This plasma component has now been isolated and partially purified in our laboratory, and tentatively designated as “Anti-XaI”.In experiments employing purified components, when Anti-XaI was incubated at 37°C with F.Xa, Xal and heparin for two minutes at pH7.5, the amount of F.Xa inhibited was inversely proportional to the Anti-XaI concentration. But, when the F.Xa was replaced by thrombin in the incubation mixture, the neutralization of thrombin clotting activity was undisturbed.Anti-XaI was found to be neither PF3 nor PF4.These and other data strongly suggest that the “Antithrombin III pathway” is more complex than currently believed to be. In circulating blood an equilibrium state must exist between Anti-XaI and XaI.Under certain conditions when the Anti-XaI activity is predominant the rate of F.Xa neutralization bv XaI then becomes slower than the activation of prothrombin to thrombin by F.Xa.

scholarly journals Studies on Thrombopoiesis. I. A Factor in Normal Human Plasma Required for Platelet Production; Chronic Thrombocytopenia Due to its Deficiency

Blood ◽  
1960 ◽  
Vol 16 (1) ◽  
pp. 943-957 ◽  
Author(s):  
IRVING SCHULMAN ◽  
MILA PIERCE ◽  
ABBY LUKENS ◽  
ZINET CURRIMBHOY
Keyword(s):  
Human Plasma ◽  
Normal Blood ◽  
Normal Human Plasma ◽  
Thrombocytopenic Purpura ◽  
Blood Banking ◽  
Platelet Production ◽  
Congenital Deficiency ◽  
Normal Plasma ◽  
Normal Human ◽  
Stimulating Factor

Abstract 1. A case of chronic thrombocytopenic purpura has been presented in which the pathogenesis appears to be due to congenital deficiency of a platelet-stimulating factor. 2. The factor exists in normal plasma and is stable on storage under normal blood banking conditions and on freezing. 3. The factor appears to act by stimulating megakaryocyte maturation and platelet production in an orderly and sequential manner.

scholarly journals STUDIES ON THE EFFECT OF A. H. P. (NORMAL HUMAN PLASMA, DRIED SINGLE DONOR, ANTIHEMOPHILIC) INFUSIONS ON HEMOPHILIA AND HEMOPHILIA-LIKE DISEASE

1962 ◽  
Vol 9 (1) ◽  
pp. 1-15
Author(s):  
Sotoharu YAMADA ◽  
Kumano IZUCHI ◽  
Michio ISOMURA ◽  
Ryoichi NAITO ◽  
Shinichi MORISUE ◽  
...  
Keyword(s):  
Human Plasma ◽  
Normal Human Plasma ◽  
Single Donor ◽  
Normal Human

Blood Coagulation Inhibitor in a Snake Plasma (Bothrops jararaca)

1973 ◽  
Vol 30 (01) ◽  
pp. 106-113 ◽  
Author(s):  
Linda Nahas ◽  
Ferruccio Betti ◽  
Aura S. Kamiguti ◽  
Hissae Sato
Keyword(s):  
Human Plasma ◽  
Blood Coagulation ◽  
Antithrombin Iii ◽  
The Other ◽  
Normal Human Plasma ◽  
Clotting Time ◽  
Bovine Thrombin ◽  
Heat Stable ◽  
Coagulation Inhibitor ◽  
Normal Human

SummaryExperiments with plasmas samples from the snake B. jararaca and X. merremii have shown that the two differ markedly with respect to their reaction to bovine thrombin. The plasma of X. merremii appears to react in a manner very similar to that of normal human plasma both using the thrombin clotting test and using the antithrombin III assay of Astrup and Darling (Biggs and Macfariane 1962). The plasma of B. jararaca on the other hand, contains, in addition to antithrombin III, an inhibitor which resembles mammalian heparin. This inhibitor prolongs the thrombin clotting time of human and X. merremii plasmas, is recorded by the antithrombin assay and is neutralized by protamine. The inhibitor is however, not identical with mammalian heparin since it is not adsorbed by BaSO4 and Al(OH)3 (which adsorb heparin) and it is heat labil whereas mammalian heparin is heat stable.

A Hitherto Undescribed Naturally Occurring Plasma Antagonist of Activated Factor X Inhibitor (Antithrombin III)

1979 ◽  
Author(s):  
E.T. Yin ◽  
W.J. Salsgiver ◽  
O. Tangen
Keyword(s):  
Equilibrium State ◽  
Human Plasma ◽  
Antithrombin Iii ◽  
Circumstantial Evidence ◽  
Incubation Mixture ◽  
Factor X ◽  
Normal Human Plasma ◽  
Plasma Component ◽  
Naturally Occurring ◽  
Normal Human

Circumstantial evidence suggested that normal human plasma contained a substance regulating the neutralization of F. Xa by F. Xa inhibitor (XaI), (Yin et.al., Adv. Exper. Med.& Biol., 52: 239, 1975, Plenum Press, N.Y.).This plasma component has now been isolated and partially purified in our laboratory, and tentatively designated as “Anti-Xal”.In experiments employing purified components, when Anti-Xal was incubated at 37°C with F. Xa. Xal and heparin for two minutes at pH7.5, the amount of F. Xa inhibited was inversely proportional to the Anti-XaI concentration. But, when the F. Xa was replaced by thrombin in the incubation mixture, the neutralization of thrombin clotting activity was undisturbed. Anti-Xa I was found to be neither PF3 nor PF6.These and other data strongly suggest that the “Antithrombin ill pathway” is more complex than currently believed to be. In circulating blood an equilibrium state must exist between Anti-Xal and Xal. Under certain conditions when the Anti-Xal activity is predominant the rate of F.Xa neutralization by Xal then becomes slower than the activation of prothrombin to thrombin by F.Xa.

Plasma Inhibition of the Heparin Accelerated Neutralisation of Xa by Antithrombin

1979 ◽  
Author(s):  
I.R. MacGregor ◽  
D.A. Lane ◽  
V.V. Kakkar
Keyword(s):  
Human Plasma ◽  
Synthetic Peptide ◽  
Antithrombin Iii ◽  
Coagulation Factors ◽  
Normal Human Plasma ◽  
Platelet Factor ◽  
Peptide Substrates ◽  
Normal Human ◽  
Heparin Fractions ◽  
Inhibition Of Thrombin

The ability of heparin fractions of different MW (mean MW 8500-30,000) to potentiate the action ot antithrombin III against the coagulation factors thrombin and Xa has been examined in purified reaction mixtures and in plasma. Residual thrombin and Xa have been determined by their peptidase activities against the synthetic peptide substrates H-D-Phe Pip-Arg-pNA and Bz-Ile-Glu-Gly-Arg-pNA. High MW heparin fractions were found to have higher anticoagulant activities than low MW heparin when studied with both thrombin and Xa incubation mixtures in purified mixtures. The inhibition of thrombin by heparin fractions and antithrombin III was unaffected by other plasma components. However, normal human plasma contained a component that inhibited the heparin and antithrombin III inhibition of Xa, particularly when the high MW heparin fraction was used. Experiments using a purified preparation of platelet factor 4 suggested that this platelet derived heparin neutralising protein was not responsible for the inhibition and that a hitherto undescribed inhibitor of heparin action is present in plasma. Preliminary studies have indicated that the inhibitor is concentrated in a fraction rich in lipoprotein and obtained by ultracentrifugation of plasma in high density salt.

Performances of an Artificial Reagent for the One-stage Factor IX Assay

1975 ◽  
Vol 33 (03) ◽  
pp. 547-552 ◽  
Author(s):  
L Meunier ◽  
J. P Allain ◽  
D Frommel
Keyword(s):  
Human Plasma ◽  
Factor Ix ◽  
Severe Haemophilia ◽  
Normal Human Plasma ◽  
Haemophilia B ◽  
One Stage ◽  
Normal Human ◽  
The One

SummaryA mixture of adsorbed normal human plasma and chicken plasma was prepared as reagent for factor IX measurement using a one-stage method. The substrate was found to be specific for factor IX. Its performances tested on samples displaying factor IX activity ranging from <l%–2,500% compared favorably with those obtained when using the plasma of severe haemophilia B patients as substrate.

Sign in / Sign up

Export Citation Format

Share Document